• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Leukemia, Plasma Cell

Leukemia, Plasma Cell - 19 Studies Found

Completed : Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia
: Primary Plasma Cell Leukemia
: 2012-03-03
: Drug: Lenalidomide, dexamethasone Enrolled patients receiv
Completed : Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia
:
  • Plasma Cell Leukemia
  • Multiple Myeloma

: 2011-03-29
:
  • Drug: Bortezomib

Terminated : Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
:
  • Multiple Myeloma
  • Leukemia, Plasma Cell

: 2012-08-03
:
  • Drug: Carfilzomib
  • Drug: Melphalan

Completed : Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70
: Multiple Myeloma
: 2016-08-04
: Drug: PAD-VCD 12 weeks of induction chemotherapy by liposomal Bortezomib-Dexamethasone-Doxorubicin (PAD)
Completed : Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants
:
  • Multiple Myeloma
  • Plasma Cell Leukemia

: 2006-03-23
:
  • Drug: Bortezomib the maximum t

Completed : A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
: Multiple Myeloma, Plasma Cell Leukemia
: 2010-11-24
:
  • Drug: ARRY-520, KSP(Eg5) inhibitor; intravenous

Completed : Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
:
  • Plasma Cell Leukemia
  • Recurrent Plasma Cell Myeloma

: 2015-07-20
:
  • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Withdrawn : Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma
:
  • Multiple Myeloma
  • Plasma Cell Leukemia

: 2014-12-09
: Drug: Bendamustine Given IV Other Names:
Completed : A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
:
  • Multiple Myeloma
  • Plasma Cell Leukemia

: 2009-01-09
:
  • Drug: ARRY-520, KSP(Eg5) inhibitor; intravenous

Terminated : Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen
:
  • Multiple Myeloma
  • Plasma Cell Leukemia

: 2008-01-22
:
  • Drug: Fludarabine/Busulfan x 4 days

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.